SAN

99.03

-4.24%↓

SHL.DE

49.57

-1.25%↓

ARGX

531.2

-2.75%↓

FRE

39.07

-1.56%↓

PHIA

23.02

-2.46%↓

SAN

99.03

-4.24%↓

SHL.DE

49.57

-1.25%↓

ARGX

531.2

-2.75%↓

FRE

39.07

-1.56%↓

PHIA

23.02

-2.46%↓

SAN

99.03

-4.24%↓

SHL.DE

49.57

-1.25%↓

ARGX

531.2

-2.75%↓

FRE

39.07

-1.56%↓

PHIA

23.02

-2.46%↓

SAN

99.03

-4.24%↓

SHL.DE

49.57

-1.25%↓

ARGX

531.2

-2.75%↓

FRE

39.07

-1.56%↓

PHIA

23.02

-2.46%↓

SAN

99.03

-4.24%↓

SHL.DE

49.57

-1.25%↓

ARGX

531.2

-2.75%↓

FRE

39.07

-1.56%↓

PHIA

23.02

-2.46%↓

Search

EssilorLuxottica SA

Atidarymo kaina

SektoriusSveikatos priežiūra

264.8 -0.82

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

265.8

Max

268.7

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-371M

994M

Pardavimai

-72M

13B

P/E

Sektoriaus vid.

52.729

73.239

Pelnas, tenkantis vienai akcijai

2.976

Dividendų pajamingumas

1.48

Pelno marža

7.52

Darbuotojai

153,498

EBITDA

635M

3.6B

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+8.59% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

1.48%

3.06%

Kitas uždarbis

2025-04-17

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

2.3B

124B

Ankstesnė atidarymo kaina

265.62

Ankstesnė uždarymo kaina

264.8

Naujienos nuotaikos

By Acuity

36%

64%

118 / 386 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Strong Bearish Evidence

EssilorLuxottica SA Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-02-12 18:35; UTC

Uždarbis

Ray-Ban Maker EssilorLuxottica Logs Higher Sales Amid North America, China Growth -- Update

2025-02-12 17:32; UTC

Uždarbis

Ray-Ban Maker EssilorLuxottica Posts Higher Profit on Sales Growth

2025-01-02 17:29; UTC

Įsigijimai, susijungimai, perėmimai

EssilorLuxottica Buys AI Startup in Hearing Market Push

2025-03-28 08:57; UTC

Rinkos pokalbiai

EssilorLuxottica Should Be Able to Cope With U.S. Volatility -- Market Talk

2025-02-13 11:05; UTC

Rinkos pokalbiai
Uždarbis

EssilorLuxottica Seems Poised to Ride the Technology Wave -- Market Talk

2025-02-13 10:54; UTC

Rinkos pokalbiai
Uždarbis

EssilorLuxottica's Midterm Margin Target Seems Challenging -- Market Talk

2025-02-13 08:41; UTC

Rinkos pokalbiai
Uždarbis

EssilorLuxottica's Sales Are Better Than Expected -- Market Talk

2025-02-12 17:05; UTC

Uždarbis

EssilorLuxottica Backs Mid-Term Targets

2025-02-12 17:05; UTC

Uždarbis

EssilorLuxottica 2024 Oper Pft EUR3.45B

2025-02-12 17:04; UTC

Uždarbis

Analysts Had Seen EssilorLuxottica 2024 Net Pft at EUR2.50B

2025-02-12 17:04; UTC

Uždarbis

EssilorLuxottica 2024 Net Pft EUR2.36B

2025-02-12 17:03; UTC

Uždarbis

EssilorLuxottica 2024 Rev EUR26.51B

2025-02-12 17:03; UTC

Uždarbis

EssilorLuxottica 4Q Rev EUR6.78B

2025-02-12 17:01; UTC

Uždarbis

Analysts Had Seen EssilorLuxottica 4Q Rev at EUR6.68B

2025-02-12 17:00; UTC

Uždarbis

EssilorLuxottica Declares Dividend of EUR3.95 a share

2025-02-11 16:30; UTC

Rinkos pokalbiai

EssilorLuxottica Has Bright Future Ahead Amid Smart Glasses Push -- Market Talk

2025-02-11 10:58; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

EssilorLuxottica Continues Ophthalmology Expansion With Cellview Acquisition -- Market Talk

2025-02-11 07:03; UTC

Įsigijimai, susijungimai, perėmimai

EssilorLuxottica Doesn't Disclose Financial Details

2025-02-11 07:03; UTC

Įsigijimai, susijungimai, perėmimai

EssilorLuxottica Aims to Build Wider Portfolio of Ophthalmic Instruments, Services With Deal

2025-02-11 07:02; UTC

Įsigijimai, susijungimai, perėmimai

EssilorLuxottica: Toronto-Based Cellview Specializes in Diagnostic via Retinal Imaging

2025-02-11 07:01; UTC

Įsigijimai, susijungimai, perėmimai

EssilorLuxottic Acquires Canadian Med-Tech Startup Cellview

2025-02-11 07:00; UTC

Įsigijimai, susijungimai, perėmimai

EssilorLuxottica to Buy Cellview

2025-01-02 17:04; UTC

Įsigijimai, susijungimai, perėmimai

EssilorLuxottica Didn't Disclose Financial Details

2025-01-02 17:03; UTC

Įsigijimai, susijungimai, perėmimai

EssilorLuxottica: This Allows People With Hearing Impairment to Better Understand Speech

2025-01-02 17:02; UTC

Įsigijimai, susijungimai, perėmimai

EssilorLuxottica: Pulse Audition Delivers AI-based Noise Reduction, Voice Enhancement

2025-01-02 17:01; UTC

Įsigijimai, susijungimai, perėmimai

EssilorLuxottica Acquires Pulse Audition

2025-01-02 17:00; UTC

Įsigijimai, susijungimai, perėmimai

EssilorLuxottica Strengthens Its Presence in Hearing Space With Acquisition of AI-driven Tech Startup in France

2024-12-03 16:21; UTC

Rinkos pokalbiai

EssilorLuxottica Could Be Hit by U.S. Tariffs -- Market Talk

2024-11-06 09:01; UTC

Rinkos pokalbiai

European Luxury Stocks Get Boost From Trump Potential Win -- Market Talk

2024-10-18 07:08; UTC

Rinkos pokalbiai
Uždarbis

EssilorLuxottica Tries Soothe Nerves After Revenue Misses Forecasts -- Market Talk

Akcijų palyginimas

Kainos pokytis

EssilorLuxottica SA Prognozė

Kainos tikslas

By TipRanks

8.59% į viršų

12 mėnesių prognozė

Vidutinis 288.2 EUR  8.59%

Aukščiausias 335 EUR

Žemiausias 245 EUR

Remiantis 11 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines EssilorLuxottica SA kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

11 ratings

7

Pirkti

4

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

265.8 / 267.9Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Strong Bearish Evidence

Vidutinės trukmės periodas

Strong Bearish Evidence

Ilgalaikis periodas

No Evidence

Rinkos nuotaikos

By Acuity

118 / 386 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę EssilorLuxottica SA

EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America. It operates through Professional Solutions and Direct to Consumer segments. The company offers lens under the Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir, eyexpert, iWear, Humanware, and Optifog brands. It also provides finishing equipment, vision performance screening, eye examination and refractions, fitting parameter measurements, and small tools and consumables under the Essilor Instruments brand; high-tech equipment for optical surfacing, polishing, measuring, coating, and finishing, as well as consumables, tools, and services under the Satisloh brand. In addition, the company provides eyewear products under the Ray-Ban, Oakley, Persol, Oliver Peoples, Vogue Eyewear, Arnette, Alain Mikli, Costa, Bliz, Native, Luxottica, Sferoflex, Bolon, Molsion, DbyD, and Unofficial and Seen, as well as other Licensed brands. In addition, the company designs, develops, markets, and maintains lens edging and mounting instruments for opticians and prescription laboratories; and optometry instruments for eyecare professionals, schools, occupational medicine centers, military, and other institutions. It wholesales its products to independent opticians, distributors, third-party e-commerce platforms, and large retail chains in the eyecare and eyewear industry; and sells directly to consumers through the network of brick and mortar retail network and its online channels. The company was formerly known as Essilor International Société Anonyme and changed its name to EssilorLuxottica Société anonyme in October 2018. EssilorLuxottica Société anonyme was founded in 1849 and is headquartered in Paris, France.